ArticleNCHS data brief2025
Prevalence of Cardiovascular Disease Risk Factors in Adults: United States, August 2021-August 2023.
Article in NCHS data brief, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cardiovascular Prevention: Current Gaps and Future Directions.Diagnostics (Basel, Switzerland) · 2025Review
- A Systematic Review of Cardiovascular Health Screening in Michigan: Are We Doing Enough?Cureus · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: National Health and Nutrition Examination Survey data were used to determine prevalence estimates for no, one, or two or more cardiovascular disease (CVD) risk factors (uncontrolled high blood pressure, uncontrolled high blood lipids, uncontrolled high mean blood glucose as measured with hemoglobin A1c, and high body mass index) in U.S. adults age 20 and older during August 2021-August 2023. Trends are also presented from 2013-2014 through August 2021-August 2023. Methods: All participants age 20 and older with complete CVD risk factor data were included. Pregnant women were excluded. All analyses accounted for the survey's complex, multistage probability design. For August 2021-August 2023, differences in estimates between subgroups were tested using t tests. Polynomial regression models were used to test for linear and quadratic trends, accounting for unequal spacing and lengths of survey cycles. Statistical significance was set at p < 0.05 level. Key findings: During August 2021-August 2023, 36.4% of adults had no CVD risk factors, 34.9% had one, and 28.7% had two or more. The prevalence of two or more CVD risk factors was higher in men than in women. The prevalence of no CVD risk factors decreased with age, and the prevalence of one CVD risk factor increased with age. Adults with family income of 350% or more of the federal poverty level had the highest prevalence of no CVD risk factors and the lowest prevalence of two or more CVD risk factors. From 2013-2014 to August 2021-August 2023, the prevalence of two or more CVD risk factors increased.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.